You need to enable JavaScript to run this app.
Regulatory Recon: FDA Reviewers Find Novo's Semaglutide Effective Ahead of Advisory Committee GSK's Shingles Vaccine Gets First Approval in Canada (16 October 2017)
Recon
Regulatory News
Michael Mezher